TriSalus Life Sciences   Report issue

For profit Phase 1 Phase 2
Founded: Westminster CO United States (2009)

Organization Overview

First Clinical Trial
2019
NCT04270929
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

TriSalus Life Sciences | TriSalus Life Sciences, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Pancreatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 10